Nine-month interim report (Q3) 2025 (unaudited)

ALK delivers 18% global organic revenue growth with operating profit up 41% in Q3 Results were better than expected, driven by a strong momentum for tablets, adrenaline autoinjectors, and SCIT/SLIT-drops. Operating profit increased as sales growth, improved gross margin, and optimisations yielded a profit margin of 28%. The full-year outlook has been upgraded.     Q3 performance highlightsComparative figures for Q3 2024 are shown in brackets. Growth rates are stated in local...

Hørsholm, 12/11/2025 (informazione.news - comunicati stampa - economia)

Results were better than expected, driven by a strong momentum for tablets, adrenaline autoinjectors, and SCIT/SLIT-drops. Operating profit increased as sales growth, improved gross margin, and optimisations yielded a profit margin of 28%. The full-year outlook has been upgraded.    

Today, ALK upgraded the full-year outlook based on the performance in Q3 and the outlook for the remainder of the year. The changes mainly reflect the current business momentum in Europe:

: Per Plotnikof, tel. +45 4574 7527, mobile +45 2261 2525
Maiken Riise Andersen, tel. +45 5054 1434

Attachment